logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Congestive Heart Failure

    FiltersReset Filters
    18 results

    • acetazolamide

      (Acetazolamide)
      Aarkish Pharmaceuticals NJ Inc.
      Usage: Acetazolamide is indicated as adjunctive treatment for edema related to congestive heart failure, drug-induced edema, centrencephalic epilepsies, and glaucoma. It also helps prevent or alleviate acute mountain sickness symptoms in climbers, especially during rapid ascents.

    • acetazolamide

      (Acetazolamide)
      Eywa Pharma Inc
      Usage: Acetazolamide is indicated as adjunctive treatment for edema from congestive heart failure and drug-induced causes, certain types of epilepsy, various glaucoma types, and for preventing symptoms of acute mountain sickness in climbers.

    • atorvaliq

      (ATORVALIQ)
      CMP Pharma, Inc.
      Usage: ATORVALIQ is indicated to reduce the risk of cardiovascular events in adults with risk factors for coronary heart disease, type 2 diabetes, and clinically evident coronary heart disease. It also lowers LDL cholesterol in various conditions, including primary hyperlipidemia and familial hypercholesterolemia, as an adjunct to diet or other therapies.

    • captopril

      (Captopril)
      Ajanta Pharma USA Inc.
      Usage: Captopril is indicated for treating hypertension, heart failure, left ventricular dysfunction post-myocardial infarction, and diabetic nephropathy in type I diabetes patients. It is effective alone or with other antihypertensives and can improve survival and reduce hospitalizations in specific heart failure patients. Caution is advised in certain populations.

    • captopril

      (captopril)
      Method Pharmaceuticals LLC
      Usage: Captopril is indicated for treating hypertension, congestive heart failure, improving survival in post-myocardial infarction patients with left ventricular dysfunction, and diabetic nephropathy in type 1 diabetes. It is effective alone or with diuretics and required careful consideration of risks in patients with renal impairment or specific demographics.

    • chlorthalidone

      (Chlorthalidone)
      Chartwell RX, LLC
      Usage: Chlorthalidone is indicated for managing hypertension, either alone or with other antihypertensive agents, and as adjunctive therapy for edema related to congestive heart failure, hepatic cirrhosis, corticosteroid and estrogen therapy, and various renal dysfunctions, including nephrotic syndrome and chronic renal failure.

    • chlorthalidone

      (Chlorthalidone)
      Nivagen Pharmaceuticals, INC.
      Usage: Chlorthalidone is indicated for managing hypertension, either alone or with other antihypertensives, and as adjunctive therapy for edema related to congestive heart failure, hepatic cirrhosis, and certain renal dysfunctions. Its use in pregnancy is limited to pathologic edema, as routine use is inappropriate.

    • enalapril maleate

      (Enalapril maleate)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Enalapril maleate tablets are indicated for treating hypertension, symptomatic congestive heart failure, and asymptomatic left ventricular dysfunction. They can be used alone or with other antihypertensives, improving symptoms and reducing hospitalization in heart failure patients. Caution is advised in patients with specific health conditions and demographics.

    • ethacrynate sodium

      (ETHACRYNATE SODIUM)
      Leading Pharma, LLC
      Usage: Ethacrynic acid is indicated for treating edema in conditions such as congestive heart failure, liver cirrhosis, and renal disease. It is also used for short-term management of malignancy-related ascites, idiopathic edema, and pediatric patients with specific heart conditions, particularly when rapid diuresis is needed.

    • ethacrynate sodium

      (ethacrynate sodium)
      Par Pharmaceutical, Inc.
      Usage: Ethacrynate sodium is indicated for treating edema associated with congestive heart failure, liver cirrhosis, renal disease, malignancy-related ascites, idiopathic edema, lymphedema, and hospitalized pediatric patients with congenital heart disease. It is also used intravenously for rapid diuresis in acute conditions or when oral administration is impractical.